Xenobiotic Laboratories Inc.
Plainsboro Center, NJ Biotesting Division
- UEI
- K254CMCPAFJ8
- CAGE
- 4XKP0
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 107 Morgan Ln, Plainsboro Township, NJ 08536, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Assess inhibition activity of 2 test articles (TA) for general efflux and uptake transporters | National Institute on Drug Abuse | $134,500 | |
| Wuxi apptec, INC.:1194620 [23-005301] | National Institute on Drug Abuse | $71,740 | |
| To award task order 04, administrative support, under IDIQ contract no. 75N95019D00037, analytical services center for… | National Institute on Drug Abuse | $0 | |
| FY20. Analytical services center for medications development program. Task order 3 -75N95020F00192. POP - 09.24.2020… | National Institute on Drug Abuse | $0 | |
| Analytical services center for medications development program. September 25, 2019 - march 24, 2021. N01DA-19-8938. Task… | National Institute on Drug Abuse | $0 |
About Xenobiotic Laboratories Inc.
Xenobiotic Laboratories Inc. is a for-profit, foreign owned corporate entity that provides biotesting services to support drug development efforts. Through its Biotesting Division, Xenobiotic Laboratories has received multiple federal contract awards to assess inhibition activity, substrate potential, and enzyme induction potential of pharmaceutical test articles utilizing in vitro methods.
Specifically, Xenobiotic has been awarded firm fixed price purchase orders from the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to evaluate test articles' effects on human drug transporters and cytochrome P450 enzymes. Additionally, the company has received delivery orders against the National Institute on Drug Abuse's Analytical Services Center for Medications Development Program multiple award indefinite delivery/indefinite quantity contract to provide analytical services in support of developing new medications for substance abuse disorders. These awards have funded Xenobiotic's work assessing test articles on behalf of government researchers, with performance taking place at the company's New Jersey laboratory. No set-aside designations have been applied.
Xenobiotic also holds an indefinite delivery contract from the National Institute on Drug Abuse for the Analytical Services Center for Medications Development Program, which has a potential value of $9.95 million through September 2024. Under this contract vehicle, the company continues supporting the National Institute on Drug Abuse's mission to advance addiction science and develop pharmacological treatments. Task orders issued to date have funded Xenobiotic's provision of analytical services over one to two year performance periods within its laboratory facilities.
Quick answers
What is Xenobiotic Laboratories Inc.'s UEI?
Xenobiotic Laboratories Inc.'s Unique Entity ID (UEI) in SAM.gov is K254CMCPAFJ8.
What is Xenobiotic Laboratories Inc.'s CAGE code?
Xenobiotic Laboratories Inc.'s CAGE code is 4XKP0.
What is Xenobiotic Laboratories Inc.'s primary NAICS code?
Xenobiotic Laboratories Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Xenobiotic Laboratories Inc. located?
Xenobiotic Laboratories Inc.'s physical address in SAM.gov is 107 Morgan Ln, Plainsboro Township, NJ 08536, USA.
Is Xenobiotic Laboratories Inc. registered in SAM.gov?
Yes. Xenobiotic Laboratories Inc.'s SAM.gov registration is active through January 28, 2027.
What is Xenobiotic Laboratories Inc.'s most recent federal award?
Xenobiotic Laboratories Inc.'s most recent federal contract award is Assess inhibition activity of 2 test articles (TA) for general efflux and uptake transporters (75N95023P00584), from National Institute on Drug Abuse, on September 20, 2023.
On GovTribe
See Xenobiotic Laboratories Inc.'s full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors